@davehartin I appreciate that the NNT website is indisputable for you. Since you are U.K. based, have you check @cochranecollab review on this. https://t.co/Jh6Sf3ZVIn
@fluidloading @PelvicFlour @qffwffq Je ne suis pas de ce milieu et ne connaissait pas le sujet avant aujourd'hui. D'après la cochrane https://t.co/IAz2J5ByAq ça a quand même l'air d'un traitement efficace ? Si vous avez les sources qui montrent que c'est t
@4mmk36 @SZehtabchi @TheSGEM @First10EM @CCREM2 @thenntgroup There are 3 reviews in question: Donaldson https://t.co/dJp87WKPDA Emberson https://t.co/mSUlcNx59G Wardlaw (Cochrane) https://t.co/B8KvR6lvIR 2/x
RT @EvidSynIRL: Finally, we have a major update to an important @CochraneLibrary review with clinical practice implications on treatment fo…
RT @EvidSynIRL: Finally, we have a major update to an important @CochraneLibrary review with clinical practice implications on treatment fo…
RT @EvidSynIRL: Finally, we have a major update to an important @CochraneLibrary review with clinical practice implications on treatment fo…
RT @CochraneIreland: Exciting opportunity on a high-impact and important Cochrane review for #stroke @saoltagroup @GalwayNchd @HSEResearch
Exciting opportunity on a high-impact and important Cochrane review for #stroke @saoltagroup @GalwayNchd @HSEResearch
RT @EvidSynIRL: Finally, we have a major update to an important @CochraneLibrary review with clinical practice implications on treatment fo…
Finally, we have a major update to an important @CochraneLibrary review with clinical practice implications on treatment for #stroke with @CochraneStroke - Read the original review (which has >1700 citations and used in 8 guidelines) here: https://t.co/
@apandersen Hej Andreas. Hidtil har man ikke tilbudt trombolyse til dem der vågner med lammelser pga. tidsgrænsen. Men også ved trombolyse< 4,5 timer er der flere der dør, mens også flere kan undgå svære handikap. God trade-off? https://t.co/xiW5EX23EY
@TheSGEM @umanamd @emresidents @SAEM_RAMS @CAEPResidents @emergmedottawa @MacEmerg @UCalgaryEM @WUSTL_EM @Qemerg @HeatherM211 @munsifio @TheSGEM you have a good point! Thank you for the answers! The same cochrane made this review about the thromolysis Ward
@DrZalaquett El negacionismo a este respecto me parece irresponsable. La trombólisis iv está lejos de ser la panacea, pero disminuye discapacidad de manera significativa en < 4,5 h. Incluso hay nuevos estudios en 4.5 -9 h con imagen avanzada https://t.
Cochrane Library https://t.co/YpoCOuErWP
@drphiliplee1 @emergencymedSpR @ella_corrick @ThomasJPaddock @DrLindaDykes My understanding of stroke thrombolysis is that it reduces disability, thereby mitigating years of care costs. https://t.co/k1GmEyW71l @cochranecollab @BASP_TE
@drjohnm As a stroke doc I look at the totality of the alteplase evidence to guide my treatment decisions, despite the limitations of individual trials. Cite me one trial which has none. The evidence for alteplase is here https://t.co/v1tZ9OLzoT or here ht
This Cochrane analysis show benefit at odd ratio of 0.8 and ICH risk at odds ratio of 3 plus . https://t.co/c77gTURAWG
The tPA in stroke @Cochrane view https://t.co/9hnIinFZEI
@Vilavaite a) one swallow doesn't make a summer - systematic review shows net benefit b) most folk more interested in *independence* than survival, per se https://t.co/myTFmzH9hI
Растворяющие тромб (тромболитические) лекарства в лечении острого ишемического инсульта на ранних стадиях https://t.co/ZCY4l9Y9n4
Thrombolysis for acute ischaemic stroke in #norwegian https://t.co/UOfRhbwHOL #Cochrane Wiley https://t.co/jTgh3xSUsV
@DrHowieMell @FLTDOC1 @genentech just read the citation Dr Howie Mell posted & U will see 3 hr window benefit. https://t.co/rNgoLJn0iQ
.@cgzammit @FLTDOC1 @AAMS ATLANTIS-B - stopped early, no benefit, and the latest Cochrane review was mixed (https://t.co/r07LNQEqpM)
Thrombolysis for acute ischaemic stroke - Wardlaw - 2014 - Cochrane Database of Systematic Reviews -https://t.co/TnxV2sQIbE
Médicaments thrombolytiques pour le traitement de l'AVC ischémique aux premiers stades https://t.co/67cyjQxw2c
Cochrane review on thrombolysis in Stroke http://t.co/qbgs6GPuIS
@SmithPogue222 @DrAseemMalhotra @djnicholl the 2014 Cochrane review might a more reliable source than the Daily Mail http://t.co/oNENcQ5fbA
@SmithPogue222 @DrAseemMalhotra @djnicholl the 2014 Cochrane review might a more reliable source than the Daily Mail http://t.co/oNENcQ5fbA
Ishemijski moždani udar: lijekovi za otapanje ugruška nedvojbeno korisni unutar 4,5 h, čak i kod starijih pacijenata http://t.co/eDs4GZmX8j
Clot-dissolving treatmt can reduce risk of LT dependency post #stroke - updated #CochraneEvidence: http://t.co/byBpUDNVCp @CochraneStroke
Clot-dissolving treatmt can reduce risk of LT dependency post #stroke - updated #CochraneEvidence: http://t.co/byBpUDNVCp @CochraneStroke
Clot-dissolving treatmt can reduce risk of LT dependency post #stroke - updated #CochraneEvidence: http://t.co/byBpUDNVCp @CochraneStroke
Clot-dissolving treatmt can reduce risk of LT dependency post #stroke - updated #CochraneEvidence: http://t.co/byBpUDNVCp @CochraneStroke
Thrombolysis for acute ischaemic stroke The Cochrane Library Wardlaw Wiley Online Library http://t.co/gRk8QGmy5W
Comment on Wardlaw JM (2014): Thrombolysis for acute ischaemic stroke. http://t.co/MahKxB7dPV
Thrombolysis for acute stroke - the latest review by the Cochrane library... http://t.co/zOEtbsECr4
Uh-oh. "@Sunnydoc72: Thrombolysis for acute stroke - the latest review by the Cochrane library... #foamed http://t.co/GlqIOThuj7” FIGHT!
Uh-oh. "@Sunnydoc72: Thrombolysis for acute stroke - the latest review by the Cochrane library... #foamed http://t.co/GlqIOThuj7” FIGHT!
Thrombolysis for acute stroke - the latest review by the Cochrane library... http://t.co/zOEtbsECr4
Thrombolysis for acute stroke - the latest review by the Cochrane library... http://t.co/zOEtbsECr4
RT @tlassers: Do long-term benefits of clot busters outweigh short-term risks in #stroke? Updated #CochraneEvidence http://t.co/Loa778hyym
Trombolisis para ACVA→↓ muertes o dependencia hasta 6 horas post-ictus, sin límite edad, st en 3 1ª horas [Cochrane] http://t.co/GzhruxIk0e
Trombolisis para ACVA→↓ muertes o dependencia hasta 6 horas post-ictus, sin límite edad, st en 3 1ª horas [Cochrane] http://t.co/GzhruxIk0e
Trombolisis para ACVA→↓ muertes o dependencia hasta 6 horas post-ictus, sin límite edad, st en 3 1ª horas [Cochrane] http://t.co/GzhruxIk0e
Trombolisis para ACVA→↓ muertes o dependencia hasta 6 horas post-ictus, sin límite edad, st en 3 1ª horas [Cochrane] http://t.co/GzhruxIk0e
RT @NeuroimagingMSc: Published - Thrombolysis for acute ischaemic stroke #neuroimaging @CochraneStroke http://t.co/bHWWPdgGa5
RT @NeuroimagingMSc: Published - Thrombolysis for acute ischaemic stroke #neuroimaging @CochraneStroke http://t.co/9PBeo2nV72
RT @NeuroimagingMSc: Published - Thrombolysis for acute ischaemic stroke #neuroimaging @CochraneStroke http://t.co/EtBWKaqstj
Published - Thrombolysis for acute ischaemic stroke #neuroimaging @CochraneStroke http://t.co/9PBeo2nV72
RT @tlassers: Do long-term benefits of clot busters outweigh short-term risks in #stroke? Updated #CochraneEvidence http://t.co/Loa778hyym
#Cochrane Efectividad tratamiento trombolítico tras accidente cerebrovascular agudo http://t.co/cOdXwdBSkv @seneurologia @Sociedad_SEMI...
RT @tlassers: Do long-term benefits of clot busters outweigh short-term risks in #stroke? Updated #CochraneEvidence http://t.co/Loa778hyym
UPDATED Cochrane review published today: Thrombolysis for acute ischaemic #stroke http://t.co/VGc7xIP2Xe @CochraneLibrary
MT @CochraneStroke: UPDATED Cochrane review published today: Thrombolysis for acute ischaemic #stroke http://t.co/G29M8qxIvZ
Do long-term benefits of clot busters outweigh short-term risks in #stroke? Updated @CochraneLibrary review http://t.co/p5vXlCInM6
Cochrane Review http://t.co/2EGvLqCuGj No difference in outcomes across time windows. Time is NOT Brain #FOAMed #emcritconf
Cochrane Review http://t.co/2EGvLqCuGj No difference in outcomes across time windows. Time is NOT Brain #FOAMed #emcritconf
@broomedocs #BroomeJMOs hmm but wasn't IST-3 to evaluate extending time and age cutoffs ?good-evidence for <3hrs, <80 http://t.co/qgE5tl8kia